The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
98339654 9833965 4 F 20130329 20160712 20140122 20160714 EXP IN-BRISTOL-MYERS SQUIBB COMPANY-20068789 BRISTOL MYERS SQUIBB JAIN D. FERTILITY AND PREGNANCY OUTCOME IN A WOMAN WITH CLASSIC CONGENITAL ADRENAL HYPERPLASIA. BMJ CASE REP. 2013;1-5 0.00 DY F Y 1.75000 KG 20160714 OT IN IN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
98339654 9833965 1 PS METFORMIN HYDROCHLORIDE. METFORMIN HYDROCHLORIDE 1 Transplacental 500 MG, QD U 20357 500 MG QD
98339654 9833965 2 SS CLOMIPHENE CITRATE. CLOMIPHENE CITRATE 1 Transplacental 100 MG, UNK U 0 100 MG
98339654 9833965 3 SS BETAMETHASONE. BETAMETHASONE 1 Transplacental U 0
98339654 9833965 4 SS RITODRINE RITODRINE 1 Transplacental U 0
98339654 9833965 5 SS PROGESTERONE. PROGESTERONE 1 Transplacental MICRONISED U 0
98339654 9833965 6 SS PROGESTERONE. PROGESTERONE 1 Transplacental 100 MG, UNK U 0 100 MG
98339654 9833965 7 SS PREDNISOLONE. PREDNISOLONE 1 Transplacental 5 MG, UNK U 0 5 MG
98339654 9833965 8 SS PREDNISOLONE. PREDNISOLONE 1 Transplacental 6.25 MG, UNK U 0 6.25 MG
98339654 9833965 9 SS PREDNISOLONE. PREDNISOLONE 1 Transplacental 7.5 MG, UNK U 0 7.5 MG
98339654 9833965 10 SS PREDNISOLONE. PREDNISOLONE 1 Transplacental 8.75 MG, UNK U 0 8.75 MG
98339654 9833965 11 C FOLIC ACID. FOLIC ACID 1 Transplacental 5 MG, UNK U 0 5 MG
98339654 9833965 12 C CALCIUM CALCIUM 1 Transplacental UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
98339654 9833965 1 Product used for unknown indication
98339654 9833965 2 Product used for unknown indication
98339654 9833965 3 Product used for unknown indication
98339654 9833965 4 Product used for unknown indication
98339654 9833965 5 Product used for unknown indication
98339654 9833965 7 Product used for unknown indication
98339654 9833965 11 Product used for unknown indication
98339654 9833965 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
98339654 9833965 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
98339654 9833965 Exposure during breast feeding
98339654 9833965 Foetal exposure during pregnancy
98339654 9833965 Premature baby

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
98339654 9833965 7 2012 0
98339654 9833965 8 20121121 0
98339654 9833965 9 20121214 0
98339654 9833965 10 20130221 0